Can (hyperbaric) oxygen turn off the motor of multiorgan dysfunction?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Reperfusion Microvascular Ischemia After Prolonged Coronary Occlusion: Implications And Treatment With Local Supersaturated Oxygen Delivery.Hypoxia (Auckland, N.Z.) · 2019
   Article
2. Hyperbaric oxygen therapy as a sole agent is not immunosuppressant in a highly immunogenic mouse model.Bone marrow research · 2011
   Article
3. Improved short-term survival with polyethylene glycol modified hemoglobin liposomes in critical normovolemic anemia.Intensive care medicine · 2008
   Article
4. Year in review in Intensive Care Medicine, 2006. I. Experimental studies. Clinical studies: brain injury, renal failure and endocrinology.Intensive care medicine · 2007
   Review

Corrections and comments

• Comment on
  Hyperbaric oxygen therapy prevents coagulation disorders in an experimental model of multiple organ failure syndrome.2006

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as